ÖZ Amaç Method: This study has been designed as a descriptive and sectional study and the sample of this research consisted of 101 women who applied to the menopause clinic of a university hospital in Istanbul and agreed to participate in research between 8 January-28 February 2014 and Data were collected using the questionnaire form which was prepared by the investigator in line with the literature and questionnaire form which consisted of questions related to socio-demographic and obstetric characteristics and Multidimensional Scale of Perceived Social Support (MSPSS)

ÖZ Amaç

Objective Premenstrual Syndrome (PMS) and Premenstrual Dysphoric Disorder (PMDD) are experienced in the luteal phase among women of reproductive age and affect the quality of life. This study sought to determine the prevalence and correlates of PMS and PMDD in women aged 18-25. Method A cross-sectional study was conducted between December 2022 and May 2023, which recruited 1125 female college students. A personal information form, the International Physical Activity Questionnaire, and the Premenstrual Syndrome Scale (PMSS) were administered. Participants who met the criteria for PMS during three consecutive menstrual cycles based on the ACOG and PMSS scores were diagnosed as having PMS. Participants who met the criteria for PMDD during three consecutive menstrual cycles based on the DSM-V were diagnosed as having PMDD. Logistic regression analysis was used to determine independent correlates of PMS and PMDD. Findings PMS was found in 49.2% and PMDD in 48.0% of the participants. Women having a B blood group compared to those with A blood group were more likely to have PMS (OR = 151.80, 95% = 54.50-422.57). In addition, women with PMS were less likely to be physically active based on the metabolic equivalent of task score (OR = 0.99,95% = 0.98-0.99). Menstrual cycle duration was also longer among those with PMDD (OR = 1.47, 95% = 1.25-1.72), as was daily caffeine intake (OR = 1.01,95% = 1.00-1.01). PMSS score was also found to be associated with MDD (OR = 1.06,95% = 1.05-1.07). Conclusions PMS and PMDD are associated with blood groups, MET scores, and other clinical characteristics that may help clinicians to identify these conditions among young women in Turkey.

Objective: The study aimed to identify the effects of restless legs syndrome (RLS) on sleep quality and quality of life in pregnant women.Methods: This comparative and descriptive study was conducted with 109 pregnant women between the 24 and 39 weeks of gestation. The presence and severity of RLS were investigated using the International Restless Legs Syndrome Study Group’s Diagnostic Criteria Scale and Severity Rating Scale, and the effects of the syndrome on sleep and quality of life were evaluated. Results: The prevalence of RLS in pregnant women was found to be 47.7%. In the RLS group, 22.0% of the pregnant women had severe RLS symptoms and 20.2% had moderate RLS symptoms. The mean score for Restless Legs Syndrome Severity Rating Scale was determined 20.75±6.38. The mean score for quality of life scale was determined 17.75±3.73 in RLS group and 26.46±2.67 in non-RLS group. Conclusion: The difference between the mean scores for Pittsburgh Sleep Quality Index of the pregnant women with RLS and those without the syndrome was found to be statistically significant. While the mean score for Quality of Life Scale in pregnant women with RLS was lower in general health, physical health and psychological health sub-dimensions, no statistically significant difference was found in social relations and environment sub-dimensions. It is recommended that nurses investigate RLS complaints of pregnant women and include non-pharmacological methods in their nursing practices.